Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
Viz.ai Appoints Dr. Timothy N. Showalter as First Chief Medical Officer
Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, has appointed Tim Showalter, MD, MPH, MBA, as its first Chief Medical Officer. Dr. Showalter, an experienced academic radiation oncologist, will guide Viz.ai’s clinical strategy and help advance the company’s mission of using artificial intelligence to expand access to life-saving care. He will report directly to Chris Mansi, MD, CEO and co-founder of Viz.ai.
Lupus Research Alliance Launches New Fund for Innovation
The Lupus Research Alliance, the world’s largest private funder of lupus research, announced the formation of a new philanthropic venture fund Lupus Ventures. The Fund is dedicated to advancing treatments and diagnostics for systemic lupus erythematosus (SLE), its manifestations, and related autoimmune conditions.
Tolion Health AI Adds Dr. Gregory J. Moore to Board
Tolion Health AI, a digital health company developing artificial intelligence solutions for personalized, predictive, and preventive brain-health guidance, announced the appointment of Gregory J. Moore, MD, PhD, to its Board of Directors. Dr. Moore brings experience as a physician-scientist, neuroradiologist, engineer, and healthcare technology leader, having overseen global teams at both Microsoft and Google where he applied AI and data platforms across healthcare and life sciences. Dr. Moore’s appointment reinforces Tolion’s commitment to uniting clinical expertise with cutting-edge technology to drive innovation in preventive brain health.
Compass Pathways Partners with Radial to Enhance COMP360 Delivery
Compass Pathways plc, a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced it is entering into its seventh strategic collaboration, with Radial Health, Inc., a growing national network of interventional psychiatry practices leveraging technology and operations expertise to optimize models of care delivery. This collaboration will further help to inform the development of scalable delivery models for investigational COMP360 psilocybin treatment, if FDA approved. The agreement with Radial expands the set of collaborations that Compass has established representing a broad spectrum of settings where people living with mental health conditions receive their care in the United States.
SpliceBio Appoints Don Munoz as Chief Financial Officer
SpliceBio, a clinical-stage company developing genetic medicines through protein splicing to treat diseases caused by mutations in large genes, announced that Don Munoz has joined the company as Chief Financial Officer. Based in Boston, Munoz is an experienced biotechnology finance executive with extensive expertise in financial strategy, corporate development, and operations, supported by a strong background in healthcare investment banking.
Orthopedic Care Partners Welcomes Rob Scoskie as Chief Development Officer
Orthopedic Care Partners has appointed Rob Scoskie as Chief Development Officer, strengthening the organization’s focus on strategic growth, market expansion, and long-term value creation. Scoskie brings over 25 years of healthcare leadership experience, including roles with physician-led networks, integrated health systems, and private equity-backed organizations. In his new role, he will oversee development strategy, including market growth, partnerships, and acquisitions, working closely with physician leaders and the executive team to guide OCP through its next phase of expansion.
To share your insights, please write to us at sudipto@intentamplify.com
